Core Insights - The insurance industry is transitioning from traditional financial compensation models to a customer-centric service model, focusing on risk reduction through proactive health management [1][4] - The establishment of the Ping An Health Management Company marks a significant step in integrating health management services with health insurance, aiming to enhance customer engagement and reduce claims [1][2] Group 1: Health Management Integration - Ping An Health has reported a service revenue of 159 million yuan in the first half of 2025, providing health management services to over 4.8 million customers, reflecting a year-on-year growth of 21.4% [2] - Other companies, such as China Pacific Insurance and China Ping An, have also established health management subsidiaries to enhance their competitive edge in the health insurance market [3][4] - Health management services are becoming a standard feature in health insurance products, even in basic insurance offerings, which now include services like health consultations and chronic disease follow-ups [2][3] Group 2: Shift from Passive to Active Management - The health insurance sector is undergoing a transformation from passive risk compensation to active health management, aiming to lower claim rates and improve customer retention [4][5] - The importance of health management is recognized as a core component for product competitiveness and sustainable industry development, especially in the context of rising health demands and clearer basic insurance roles [4][5] Group 3: Challenges and Opportunities - Despite the recognized importance of health management, low user awareness and service utilization rates remain significant challenges for the industry [5] - The Chinese government has issued guidelines to promote the integration of health insurance and health management, emphasizing the need for preventive measures and improved public understanding of health insurance [6][7] - Artificial intelligence (AI) is seen as a potential solution to enhance service delivery and efficiency in health management, with applications in personalized health interventions and dynamic assessments [6][7]

Group 1 - The A-share market is experiencing increased activity, with the margin trading balance reaching a historical high of 26,047 billion yuan as of January 7, 2026, marking a daily increase of approximately 24.8 billion yuan [1] - Since December 22, 2025, the margin trading balance has accelerated, growing by over 100 billion yuan in just 11 trading days [3] - On January 7, 2026, the margin trading transaction volume reached 3,312 billion yuan, the highest in three months, and has exceeded 3,000 billion yuan for two consecutive trading days [3] Group 2 - The overall trading volume in the A-share market reached 28,800 billion yuan on January 7, 2026, with trading volumes exceeding 28,000 billion yuan for two consecutive days [4] - Several popular A-shares achieved record trading volumes, including LeiKe Defense with 13.23 billion yuan, HaiGe Communication with 12.16 billion yuan, and NanDa Optoelectronics with 10.43 billion yuan, all marking historical highs since their listings [4] - A total of 17 stocks, including Dongfang Fortune, China Ping An, and Ningde Times, have margin trading balances exceeding 10 billion yuan, with four stocks surpassing 20 billion yuan [3]

智通财经APP获悉，摩根大通发表研究报告指出，2025年香港上市的保险股表现优于亚太区同业，其中 国人寿(02628)升87%，跑赢恒指28%的升幅。该行预期，2026年将是主要寿险公司强劲资产负债表、稳 健分销渠道及优化产品组合获得市场认可的一年。中国平安(02318)为该行首选，给予"增持"评级，目 标价上调至100港元。其次为中国人寿(02628)，目标价40港元。 对于非寿险板块，该行维持谨慎立场，对人保(01339)及财险(02328)维持"中性"评级。该行继续偏好H股 多于A股，认为H股具有更有利的风险回报状况，预计H-A股估值差距将会收窄。中国平安(02318)以 2026财年预测市盈率7倍及5%股息率交易，估值吸引。 该行同时将太保(02601)评级由"中性"上调至"增持"，反映其基本面复苏。不过，将新华保险(01336)评 级由"增持"下调至"中性"，主要由于2025年股价强劲上涨后，相对主要寿险公司的准备金质量差距扩 大。 ...

Investment Rating - The investment rating for the company is "Outperform the Market" (maintained) [1] Core Views - The recent strength of the insurance sector, represented by the company, is driven by a combination of policy support, macroeconomic changes, fundamentals, and market capital flows [3] - The company is expected to benefit from a shift in market style from high-growth stocks to value stocks, with its low valuation and high dividend yield providing defensive value [14][26] - The company's strategic focus on "comprehensive finance + ecosystem" aligns well with the aging economy and domestic demand themes, creating a solid second growth curve [5][15] Summary by Sections Market Dynamics - Since December 2025, the A-share insurance sector has seen a maximum monthly increase of 20%, with the company achieving a near four-year high [2] - The appreciation of the RMB has attracted foreign capital to reallocate to core Chinese assets, with the company being a key choice due to its liquidity and low valuation [3][11] Internal and External Factors - Internally, the high-quality development of public funds is expected to lead to a shift from growth to value style by 2026, increasing demand for the company's low valuation and high dividend attributes [3][8] - Externally, the strategic allocation of overseas capital to Chinese assets is anticipated to rise, benefiting stable and high-dividend companies like the company [4][11] Strategic Initiatives - The company is investing in health and wellness, which aligns with the aging population's needs and domestic consumption policies, enhancing the value of its insurance products [15][22] - The integration of AI technology into its operations is expected to improve efficiency and service quality, further solidifying its competitive advantage [22][23] Financial Projections - The company maintains its earnings per share (EPS) forecasts for 2025 to 2027 at 7.72, 8.57, and 9.26 CNY per share, with current price-to-embedded value (P/EV) ratios of 0.71, 0.65, and 0.59x [3][26] - The expected annual growth rate of the company's embedded value (EV) over the next three years is approximately 11%, with a reasonable P/EV valuation range of 1.02 to 1.13 [3][26]

在A股市场整体行情和成交趋向活跃的同时，作为A股市场的一股重要力量，两融资金的规模和参与度也 正在快速提升。 数据显示，截至2026年1月7日，A股市场两融余额达26047亿元，首次突破2.6万亿元大关，并进一步创出 历史新高，单日增长约248亿元。 值得注意的是，近段时间以来，两融余额规模的增长再次加速，自2025年12月22日以来，短短11个交易 日，两融余额累计已经增长超过1000亿元。 比如，雷科防务当日成交额首次突破百亿元，达到132.3亿元，创出该股上市以来的历史新高，其全天成交 8.42亿股，创出历史新高。 当天海格通信成交额也历史性地首次突破百亿元，达到121.6亿元，创出该股上市以来的历史新高，其全天 成交6.12亿股，亦创出历史新高。 此外，当天南大光电成交额也历史性地首次突破百亿元，达到104.3亿元，创出该股上市以来的历史新高， 其全天成交1.96亿股，亦创出历史新高。 责编：万健祎 校对： 苏焕文 版权声明 证券时报各平台所有原创内容，未经书面授权，任何单位及个人不得转载。我社保留追 究相关 行 为主体法律责任的权 利。 转载与合作可联系证券时报小助理，微信ID：Securities ...

对于非寿险板块，该行维持谨慎立场，对人保(01339)及财险(02328)维持"中性"评级。该行继续偏好H股 多于A股，认为H股具有更有利的风险回报状况，预计H-A股估值差距将会收窄。中国平安(02318)以 2026财年预测市盈率7倍及5%股息率交易，估值吸引。 该行同时将太保(02601)评级由"中性"上调至"增持"，反映其基本面复苏。不过，将新华保险（601336） (01336)评级由"增持"下调至"中性"，主要由于2025年股价强劲上涨后，相对主要寿险公司的准备金质量 差距扩大。 摩根大通发表研究报告指出，2025年香港上市的保险股表现优于亚太区同业，其中国人寿（601628） (02628)升87%，跑赢恒指28%的升幅。该行预期，2026年将是主要寿险公司强劲资产负债表、稳健分销 渠道及优化产品组合获得市场认可的一年。中国平安（601318）(02318)为该行首选，给予"增持"评 级，目标价上调至100港元。其次为中国人寿(02628)，目标价40港元。 ...

Summary of Key Points from the Conference Call Industry Overview - The report focuses on the **China Equity Strategy** and the dynamics of **foreign fund flows** into Chinese equities, particularly in the context of **A-shares** and **Hong Kong** markets [1][2]. Core Insights - **Foreign Inflows**: In December, foreign inflows into Chinese equities accelerated to **US$3.5 billion**, driven by **US$4.4 billion** from passive funds and **US$0.9 billion** from active funds [1][11]. - **Cumulative Inflows**: For 2025, cumulative foreign long-only fund inflows reached **US$14 billion**, a significant recovery compared to **US$26 billion** outflow in 2023-24 [11]. - **Market Liquidity**: Onshore equity mutual fund AUM rose sharply in December, with a net increase of **Rmb2.2 trillion** in 2025, nearly double the **Rmb1.0 trillion** increase in 2024 [11][12]. - **Sector Performance**: Active fund managers increased their positions in sectors such as **Insurance**, **Capital Goods**, and **Consumer Discretionary**, while trimming positions in **Bank**, **Pharmaceutical**, and **Consumer Durables & Apparel** [11]. Fund Flow Dynamics - **Passive vs. Active Funds**: Passive funds saw inflows of **US$4.4 billion** in December, while active funds experienced outflows of **US$0.9 billion**, indicating a shift in investor preference towards passive investment strategies [11][12]. - **Retail Participation**: Retail investor activity remained stable, with new SSE account openings slightly increasing to **2.6 million** in December, compared to **2.4 million** in November [21]. Additional Insights - **Money Market Funds**: AUM for money market funds declined to **Rmb116 billion** in December, reflecting a reallocation of assets towards equities [31]. - **Private Fund Activity**: Private fund AUM remained stable after a significant increase in October, indicating continued interest from high-net-worth investors [24]. - **Sector-Specific Trends**: Companies like **Ping An Insurance**, **PDD**, and **Alibaba** saw increased investment, while **CCB**, **Xiaomi**, and **Anta** were trimmed by active fund managers [11]. Conclusion - The overall trend indicates a positive shift in foreign investment towards Chinese equities, particularly through passive funds, while active funds are experiencing outflows. The significant increase in AUM for onshore equity mutual funds suggests a strong reallocation towards equities, reflecting investor confidence in the market's recovery.

Group 1 - Non-bank financial stocks weakened, with Huatai Securities and GF Securities dropping over 3%, while China Ping An, Guotai Junan, China Pacific Insurance, and China Life fell over 2% [1] - Securities and insurance-related ETFs declined approximately 2% [1] Group 2 - Some brokerages indicate that the fundamentals of the brokerage sector will continue to improve in 2025, but the sector is currently "stagnant" with significantly undervalued valuations; looking ahead to 2026, broker ROE is expected to return to an upward trend, with margin financing balances and derivative business becoming the main leverage direction for brokerages, and accelerated mergers and acquisitions among leading brokerages expected to enhance industry concentration [2] Group 3 - In the insurance sector, the liability side showed strong performance, with leading insurance companies leveraging product structure optimization and market concentration advantages to lay a solid foundation for annual performance growth; simultaneously, the asset side continues to show resilience, as the spring market activity is expected to improve investment returns for insurance companies, further boosting profit expectations; the low base effect from the first quarter of last year is likely to amplify this year's year-on-year performance growth [3] - The dual benefits from both the liability and asset sides strengthen the valuation repair momentum for the insurance sector [3]

Summary of Conference Call on Non-Bank Financial Sector Industry Overview - The conference call focused on the non-bank financial sector, particularly the insurance and brokerage industries, highlighting recent market trends and investment strategies. Key Points on Insurance Sector 1. **Market Performance and Expectations**: The A500 index has seen continuous capital inflow, especially around New Year, indicating positive market expectations for the insurance sector [1][3]. 2. **Insurance Sector Strength**: Since October 2025, the insurance sector has performed strongly due to several factors, including a reduction in preset interest rates, improvements in liabilities, and strong sales performance in early 2026 [1][4]. 3. **Investment Returns**: In Q3 2026, insurance companies reported stable investment returns, benefiting from increased allocations to high-dividend products, which contributed to overall profitability [7]. 4. **Future Outlook for 2027**: The insurance industry is expected to see synchronized expansion in both liabilities and assets, with a focus on dividend insurance products driving capital inflow and an increase in third-party asset management [8]. 5. **High Dividend Preference**: Insurance capital is increasingly favoring high-dividend and high-return assets, with approximately 20% of new funds allocated to stock investments [10]. 6. **A and H Share Valuation**: The valuation of A shares versus H shares is influencing investment decisions, with certain H shares being attractive due to their lower price relative to A shares [11]. 7. **Dividend Yields**: Current dividend yields for major insurance companies in the H share market are around 4% for China Ping An and 3.5% for China Pacific Insurance, making them appealing to investors [12]. 8. **Asset Allocation Trends**: Insurance companies are expected to increase their allocation to high-dividend assets in response to regulatory guidance on long-term capital market participation [14]. Key Points on Brokerage Sector 1. **Brokerage Sector Performance**: The brokerage sector has experienced sluggish growth due to regulatory pressures, limiting internal growth despite favorable market conditions [15]. 2. **M&A Importance**: Mergers and acquisitions are seen as crucial for driving performance in the brokerage sector, with a focus on high-quality development and enhancing competitiveness [16][17]. 3. **Investment Strategy for 2026**: The brokerage sector may see a structural rebound in 2026, particularly in the context of seasonal market movements and monetary policy easing [18]. Additional Insights - **ETF Launch**: A new ETF focusing on the non-bank sector, with a significant allocation to insurance stocks, has been introduced, reflecting a strategic investment approach in the current market environment [19]. - **Market Dynamics**: The call highlighted the rapid rotation in market sectors, with a need for investors to adjust their strategies based on evolving market conditions and performance metrics [3][18]. This summary encapsulates the key insights and projections discussed during the conference call, providing a comprehensive overview of the current state and future outlook of the non-bank financial sector.

Group 1 - The Ministry of Industry and Information Technology and seven other departments issued the "Implementation Opinions on the Special Action of 'Artificial Intelligence + Manufacturing'", aiming to promote the deep application of 3-5 general large models in manufacturing by 2027, create 100 high-quality data sets in industrial fields, and establish 500 typical application scenarios [1][1][1] - The People's Bank of China reported that the gold reserves at the end of December reached 74.15 million ounces (approximately 2306.323 tons), an increase of 30,000 ounces (about 0.93 tons) month-on-month, marking the 14th consecutive month of gold accumulation [1][1][1] - The Ministry of Industry and Information Technology released the "Action Plan for the Integration of Industrial Internet and Artificial Intelligence", which aims to expand the scale of new industrial networks that meet the high throughput, low latency, high reliability, and low jitter communication needs by 2028, with a target of implementing new industrial network upgrades in no less than 50,000 enterprises [1][1][1] Group 2 - The Ministry of Commerce announced an anti-dumping investigation on imported dichlorodihydrosilane from Japan, with the investigation period set from July 1, 2024, to June 30, 2025, and the industry damage investigation period from January 1, 2022, to June 30, 2025 [1][1][1] - The Shanghai Futures Exchange adjusted the price limit for silver futures contracts AG2601, AG2602, AG2603, and AG2604 to 16%, with the margin ratio for maintaining positions set at 17% and for general positions at 18% [1][1][1] - Multiple departments held a symposium on the power and energy storage battery industry, focusing on controlling production capacity, managing price wars, and protecting patents to address industry "involution" [1][1][1] Group 3 - China Ping An Life Insurance Company announced that Ping An Asset Management, entrusted with Ping An Life's funds, will invest in Agricultural Bank of China H-shares, reaching 20% of the bank's equity by December 30, 2025, triggering a mandatory disclosure under Hong Kong market rules [1][1][1] - Liyang Chip responded to rising storage prices, indicating that some product lines are experiencing tight testing capacity, leading some customers to request price increases to secure output [1][1][1] - Guanglian Aviation announced that Tianjin Yuefeng, as a core supplier for Tianbing Technology's Tianlong No. 3, will undertake the manufacturing tasks for the entire rocket storage tank and some structural components [1][1][1] Group 4 - Heng Rui Medicine announced that its innovative Class 1 drug, Rilafurpu α injection, has been approved for market launch, with no similar products approved domestically or internationally [1][1][1] - The announcement from *ST Sunshine indicated that the controlling shareholder is planning a change of control, leading to a suspension of trading [1][1][1] - The three consecutive board announcements from Pulit indicated that LCP film technology has a high barrier to entry and is the only company in China to achieve breakthroughs in this technology, collaborating with overseas clients on applications in brain-computer interfaces [1][1][1]